Adderall News and Research

RSS
Adderall (dextroamphetamine-amphetamine) is a combination of two synthetic agents with central nervous system stimulant activity. Both agents are non-catecholamine, sympathomimetic agents that elevate blood pressure and cause bronchodilation. These agents are commonly abused psychostimulant drugs that induce psychologic dependence manifested by elevated mood, increased wakefulness, concentration, physical performance and a feeling of well-being. Tolerance to various effects develops unequally, so that tachycardia and enhanced alertness diminish while psychotoxic effects (hallucinations and delusions) may occur.
Vaping among teens doubles in a year says MTF report

Vaping among teens doubles in a year says MTF report

Study finds increased prevalence of marijuana and nicotine vaping among teens

Study finds increased prevalence of marijuana and nicotine vaping among teens

Methamphetamine undermines success in treatment for opioid-use disorder

Methamphetamine undermines success in treatment for opioid-use disorder

First device-based, non-drug therapy for treating ADHD in children

First device-based, non-drug therapy for treating ADHD in children

Pediatricians stand by meds for ADHD, but some say therapy should come first

Pediatricians stand by meds for ADHD, but some say therapy should come first

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

Nonprescribed psychostimulants may boost short-term focus but impede sleep, mental functions

Study analyzes the prevalence of antipsychotic use in youths with ADHD

Study analyzes the prevalence of antipsychotic use in youths with ADHD

General public views use of cognitive enhancers as acceptable practice

General public views use of cognitive enhancers as acceptable practice

ADHD drug raising risk of psychosis

ADHD drug raising risk of psychosis

ADHD patients have increased risk of developing Parkinson's and other similar diseases

ADHD patients have increased risk of developing Parkinson's and other similar diseases

ADHD medications may fail to improve cognition in healthy college students, study shows

ADHD medications may fail to improve cognition in healthy college students, study shows

Graphic: Opioid painkiller is top prescription in 11 states

Graphic: Opioid painkiller is top prescription in 11 states

NIH awards $2 million grant to test effectiveness of nonmedication ADHD treatments

NIH awards $2 million grant to test effectiveness of nonmedication ADHD treatments

Chapman University research explores substance abuse among transgender adolescents in California

Chapman University research explores substance abuse among transgender adolescents in California

ADHD medicines linked to lower risk for substance use problems in adolescents, adults

ADHD medicines linked to lower risk for substance use problems in adolescents, adults

UB researchers explore potential side effects of stimulant drug on people without ADHD

UB researchers explore potential side effects of stimulant drug on people without ADHD

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

Shire’s Xiidra receives FDA approval for treating dry eye disease in adult patients

U-M study compares early-use and longer-duration stimulant medication with nonstimulant therapy for ADHD

U-M study compares early-use and longer-duration stimulant medication with nonstimulant therapy for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Neos announces U.S. launch of Adzenys XR-ODT for ADHD

Misuse of Adderall drug rising among young adults, research suggests

Misuse of Adderall drug rising among young adults, research suggests